Endocr Pract: Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
2008; 14:10-17. OBJECTIVE: To investigate the efficacy of cholecalciferol (vitamin D3) in raising serum 25-hydroxyvitamin D (25[OH)]D) levels and reducing parathyroid hormone (PTH) levels in patients with chronic kidney disease (CKD). METHODS: In this double-blind, randomized controlled pilot study, participants with CKD stage 3 and 4 (estimated...

Clinical Cases in Kidney Disease.
Clinical Cases in Kidney Disease Editors: David Harris Publisher: McGraw-Hill: Sydney [ILLUSTRATION OMITTED] This informative text is edited by David Harris, Professor of Medicine amd Associate Dean of the Western Clinical School of the University of Sydney, Westmead Hospital and a...

World Kidney Day: Kidney disease, common, harmful but treatable.
AMONG our vital organs, the kidney, too often overlooked in global public health efforts, has now emerged as central to prevention efforts. With more than 500 million individuals, or about one adult in 10 in the entire world having some form of kidney disease, the cumulative global cost for...

Patient-friendly e-resource recipes for patients with chronic kidney disease.
People with kidney disease often feel that their diet is restrictive and monotonous. The websites listed below offer tips and suggestions to add back flavour, excitement, and variety into healthful eating. Recipes, which were posted on these websites, were deemed to be suitable for patients at varying stages of...

MRI contrast agents tied to rare skin disease in kidney patients.
Following an FDA public health advisory issued last year concerning gadolinium dyes used in MRI, Health Canada and GE Healthcare recently reported an 71 additional reports of cases of Nephrogenic Systemic Fibrosis/ Nephrogenic Fibrosing Dermopathy (NSF/NFD) occurring in patients with kidney disease who were exposed to the contrast agent....

Pfizer: An Increase Dosage of Lipitor Reduces the Risk of Heart Attack and Stroke in Certain Patients.
HEALTH AND BEAUTY CLOSE-UP-9 August 2008-Pfizer: An Increase Dosage of Lipitor Reduces the Risk of Heart Attack and Stroke in Certain Patients(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Pfizer announced that, in patients with heart disease, type 2 diabetes and chronic kidney disease, Lipitor (a torvastatin calcium) 80 mg...

Family of man who needs new kidney work hard to raise money for dialysis.
Byline: Bill Fortier COLUMN: SOUTH COUNTY NOTEBOOK Just following up on a few items while waiting for the next severe thunderstorm to pummel South County Notebook land. We begin with the latest on Auburn resident Eric P. Walker and his search for a...

Screen asymptomatic patients for PAD.
Results from the German Epidemiological Trial on Ankle-Brachial Index (getABI), presented at the annual congress of the European Society of Cardiology, provide good evidence that there is a real need for primary care physicians to screen asymptomatic patients for peripheral artery disease (PAD). In the study, 6,880...

Inflammation: its impact on oral health and the total body.
[ILLUSTRATION OMITTED] Over the past three years in Access, we have continued to discuss the important role of inflammation in periodontal disease and its relationship to systemic diseases. Each year, we have learned more than the year before regarding the clinical research being conducted in the United...

Sleep-disordered breathing may harm kidneys.
BALTIMORE -- Nocturnal hypoxemia is associated with higher levels of urinary albumin excretion, according to results from a cross-sectional study of more than 500 men aged 67 years and older. Sleep-disordered breathing has been linked to hypertension, cardiovascular disease, and death. Additional studies also have shown that...